Drugs / BEMA Buprenorphine NX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02516436 | ? → May 2017 | opiate dependence | BioDelivery Sciences International | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BEMA Buprenorphine NX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02516436 ↗ |
| Route | Other | “Buprenorphine with naloxone in a buccal film” NCT02516436 ↗ |